By James Girards.

On July 11, 2014, the US FDA issued a notice to all healthcare providers across the country to stop using sterile medications produced by Temple, TX drug supplier Unique Pharmaceuticals because the drugs may not be sterile. The FDA Inspection reports are a frightening read and are a lesson to what not to do when operating a "sterile" laboratory. Read the FDA documents by clicking here. Presumably, in the days ahead hospitals throughout the country are going to be sending notices to all patients who received medications from this drug company.

For more information or help on any medical malpractice case or compounding pharmacy or dangerous drug case in Texas, Oklahoma, or Arkansas, contact the Girards Law Firm at one of our offices:

Dallas Office:

10000 N Central, Suite 400
Dallas, TX 75231

Phone: 214-346-9529

Arkansas office:

609 SW 8th Street, Suite 600
Bentonville, AR 72712

Phone: (501) 288-9529

Oklahoma Office:

1831 E 71st Street
Tulsa, OK 74136

Phone: 405-598-7825

Comments are closed.